High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia

@article{Almqvist2001HighIR,
  title={High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia},
  author={EW Almqvist and D Elterman and PM Macleod and M Hayden},
  journal={Clinical Genetics},
  year={2001},
  volume={60}
}
The advent of the direct mutation test for Huntington disease (HD) has made it possible to identify a previously unrecognized symptomatic population of HD, including those with an atypical presentation or patients without a family history of HD. The present study investigated the uptake of this test in the province of British Columbia (BC), Canada and assessed the incidence rate and rate of identification of new mutations for HD. All symptomatic individuals residing in BC who were referred for… 
Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing
TLDR
Direct HD genetic testing shows that the incidence and mutation rates of the disease are 2–3 times higher than previously reported, and the relevance of CAG repeat length assessment in diagnosing patients with late onset of symptoms and negative family history for HD is demonstrated.
Molecular diagnosis of Huntington disease in Portugal: implications for genetic counselling and clinical practice
TLDR
Cases posing particular problems for genetic counselling, such as, ’homozygosity’ that can pose a serious ethical dilemma, carriers of large normal alleles, and ‘homoallelism’ for a normal gene, are identified, which will demand further procedures and may delay results in presymptomatic and prenatal testing.
The Impact of Family History on the Clinical Features of Huntington's Disease.
TLDR
A positive family history of HD appears to be associated with an earlier onset of depression and overall disease manifestations, and Implications regarding the role of genetic versus environmental contributions to symptom onset in HD are discussed.
Clinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort.
TLDR
This report of late onset HD affected individuals shows a mild phenotype expression of the disease, associated with low range of CAG repeats and up to 30% of cases with absence of clear family history.
Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy
TLDR
The prevalence and incidence of HD in the northern Italian population were lower than the prevalence and occurrence reported for other European and Italian populations, but higher compared to those of Asia, Africa, and Eastern Europe.
High frequency of intermediate alleles on huntington disease‐associated haplotypes in British Columbia's general population
TLDR
It is suggested that IAs are relatively frequent in the general population and are often found on haplotypes associated with expanded CAG lengths, given that they are both found on disease‐associated haplotypes.
Epidemiology of Huntington disease.
Clinical and genetic features of Huntington disease in Sri Lanka
TLDR
The clinical and genetic features seen in patients with Huntington disease in the Sri Lankan study population were similar to that previously reported in literature.
Advances in Huntington’s disease diagnostics: development of a standard reference material
TLDR
The College of American Pathology/American College of Medical Genetics Biochemical and Molecular Genetics Resource Committee has emphasized the need to standardize the methodology for the determination of the accurate number of CAG repeats, which will prevent false-positive or -negative results when conducting predictive or prenatal testing of at-risk individuals.
Preliminary analysis of Huntington's Disease in South Korea.
TLDR
This study is the first demographic, clinical and genetic analyses in South Korea and will be helpful to stimulate more large-scale research in South Korean and other Asian nations.
...
...

References

SHOWING 1-10 OF 26 REFERENCES
Family history and DNA analysis in patients with suspected Huntington's disease.
OBJECTIVES Until recently a definite diagnosis of Huntington's disease could be made by a combination of clinical findings, a positive family history, and pathological confirmation. Prevalence data
Huntington disease without CAG expansion: phenocopies or errors in assignment?
TLDR
It is shown that on rare occasions mutations in other, as-yet-undefined genes can present with a clinical phenotype very similar to that of HD.
Late-onset Huntington's disease: a clinical and molecular study.
TLDR
It is suggested that Huntington's disease in elderly people causes predominantly motor disturbance at onset with relatively mild disability and a favourable outlook for both independent living and for life expectancy.
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium
TLDR
The introduction and establishment of HD presymptomatic testing shows that this form of predictive medicine for Mendelian disorders can be successfully incorporated into National Health Service structures.
Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases.
TLDR
A new approach for analysis of the epidemiology of progressive genetic disorders that quantifies the rate of progression of the disease in the population by measuring the mutational flow is described and implies that the new mutation rate for HD in each generation is > or = 10% of currently known cases.
A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
TLDR
CAG trinucleotide expansion is the molecular basis of Huntington's disease worldwide and is a highly sensitive and specific marker for inheritance of the disease mutation.
Molecular analysis of late onset Huntington's disease.
TLDR
This study shows that variation in repeat length only accounts for approximately 7% of the variation in age of onset for persons beyond the age of 50 and clearly shows how with increasing onset age the effect of the repeat length on this onset age seems to diminish.
A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.
TLDR
To map the disease trait segregating in this family, whole-genome screening with highly polymorphic dinucleotide-, trinucleotide, and tetranucleotide-repeat DNA markers was performed and indicated that the gene responsible for the disease is likely located in a 2.7-cM region.
Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989).
TLDR
Incidence and prevalence rates of HD in this community are similar to those reported in other communities, and the small numbers of affected persons do not allow an estimate of variation over time.
Mutation size and age at onset in Huntington's disease.
TLDR
There was a highly significant relationship between the size of the expanded region and age at onset, larger mutations being associated with earlier onset, and this association was strongest in those with onset before 25 years of age but less clear cut with later onset.
...
...